Viewing Study NCT04103892

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:38 PM
Ignite Modification Date: 2026-02-02 @ 6:30 AM
Study NCT ID: NCT04103892
Status: COMPLETED
Last Update Posted: 2025-10-14
First Post: 2019-09-09
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study
Sponsor: Clexio Biosciences Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adjunctive Treatment of Major Depressive Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDD View
None depression View
None depressive disorder View
None major depression View
None adjunct therapy View
None oral View
None esketamine View